A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of various combinations of anti-HIV
drugs in HIV-positive men and women. Patients receive specific combinations of 3 or 4 of the
following 6 drugs: didanosine (ddI), stavudine (d4T) efavirenz (EFV), nelfinavir (NFV),
lamivudine (3TC), or zidovudine (ZDV).
Anti-HIV therapy is effective in preventing the spread of HIV in the body. However, patients
often experience unpleasant side effects and have difficulties following the dosing schedule.
This study looks for combinations of anti-HIV drugs ("cocktails") which will be the most
effective with the fewest problems.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)